{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:29:05Z","timestamp":1793831345450,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["110-S4901"],"award-info":[{"award-number":["110-S4901"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW110-TDU-B-211\\u2013124002"],"award-info":[{"award-number":["MOHW110-TDU-B-211\\u2013124002"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110\\u20132628-B-002\\u2013059"],"award-info":[{"award-number":["110\\u20132628-B-002\\u2013059"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["111\\u20132314-B-002\\u2013209"],"award-info":[{"award-number":["111\\u20132314-B-002\\u2013209"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110\\u20132326-B-002\\u2013003-MY3"],"award-info":[{"award-number":["110\\u20132326-B-002\\u2013003-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biopha.2022.113710","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:35:21Z","timestamp":1663918521000},"page":"113710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection"],"prefix":"10.1016","volume":"155","author":[{"given":"Yu-Chung","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hsi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2022.113710_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113710_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jgar.2018.11.010","article-title":"Bacterial resistance in the intensive care unit of developing countries: Report from a tertiary hospital in Kazakhstan","volume":"17","author":"Viderman","year":"2019","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"10.1016\/j.biopha.2022.113710_bib3","first-page":"1","article-title":"Association between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal","author":"Serra-Burriel","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"8575\u20136","key":"10.1016\/j.biopha.2022.113710_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","article-title":"Vancomycin-resistant enterococci","volume":"1","author":"Uttley","year":"1988","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.biopha.2022.113710_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","article-title":"Vancomycin-resistant enterococcal infections","volume":"342","author":"Murray","year":"2000","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.biopha.2022.113710_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x","article-title":"Management of multidrug-resistant enterococcal infections","volume":"16","author":"Arias","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.biopha.2022.113710_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/14656560902811811","article-title":"Therapeutic options for infections due to vancomycin-resistant enterococci","volume":"10","author":"Wang","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2022.113710_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.biopha.2022.113710_bib9","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/AAC.35.9.1710","article-title":"Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs","volume":"35","author":"Hanberger","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2022.113710_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jgar.2019.10.008","article-title":"Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis","volume":"21","author":"Shi","year":"2020","journal-title":"J. Glob. Antimicrob. Resist"},{"issue":"1","key":"10.1016\/j.biopha.2022.113710_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.biopha.2022.113710_bib12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/cid\/ciy749","article-title":"Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint","volume":"68","author":"Avery","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113710_bib13","unstructured":"Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing: 29th informational supplement, M100S., CLSI, Wayne, PA., 2019."},{"issue":"5","key":"10.1016\/j.biopha.2022.113710_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/cid\/ciz079","article-title":"Concerns about the association between poor clinical outcomes and the minimum inhibitory concentrations determined by etest","volume":"69","author":"Cheng","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.113710_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jama.2016.18977","article-title":"Revised CIOMS international ethical guidelines for health-related research involving humans","volume":"317","author":"van Delden","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2022.113710_bib16","unstructured":"Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing: 31th informational supplement, M100S., CLSI, Wayne, PA., 2021."},{"issue":"8","key":"10.1016\/j.biopha.2022.113710_bib17","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cix024","article-title":"Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible enterococcus faecium bacteremia","volume":"64","author":"Chuang","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2022.113710_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"issue":"3","key":"10.1016\/j.biopha.2022.113710_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciq154","article-title":"Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia","volume":"52","author":"Chuang","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2022.113710_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"12","key":"10.1016\/j.biopha.2022.113710_bib21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"Daptomycin, Investigators, The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2022.113710_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.07.018","article-title":"Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose","volume":"22","author":"Chuang","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"issue":"9","key":"10.1016\/j.biopha.2022.113710_bib23","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/cid\/ciy287","article-title":"Effect of Statin Coadministration on the Risk of Daptomycin-Associated Myopathy","volume":"67","author":"Dare","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2022.113710_bib24","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/cid\/ciw173","article-title":"Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?","volume":"62","author":"Shukla","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2022.113710_bib25","article-title":"CRTREES: Stata module to compute Classification and Regression Trees algorithms, Statistical Software Components","author":"Mora","year":"2018","journal-title":"Boston Coll. Dep. Econ."},{"key":"10.1016\/j.biopha.2022.113710_bib26","series-title":"Model Selection and Multimodel Inference: A Practical Information-theoretic Approach","author":"Burnham","year":"2002"},{"issue":"4","key":"10.1016\/j.biopha.2022.113710_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A current perspective on daptomycin for the clinical microbiologist","volume":"26","author":"Humphries","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2022.113710_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00315-18","article-title":"Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with beta-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions","volume":"62","author":"Kebriaei","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.biopha.2022.113710_bib29","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1128\/AAC.00509-12","article-title":"Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints","volume":"56","author":"Munita","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.biopha.2022.113710_bib30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cmi.2020.04.027","article-title":"T. European Committee on Antimicrobial Susceptibility, Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper","volume":"26","author":"Turnidge","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"10.1016\/j.biopha.2022.113710_bib31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.clinthera.2015.04.008","article-title":"Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia","volume":"37","author":"Moise","year":"2015","journal-title":"Clin. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2022.113710_bib32","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1128\/AAC.47.11.3561-3566.2003","article-title":"Analysis of daptomycin efficacy and breakpoint standards in a murine model of Enterococcus faecalis and Enterococcus faecium renal infection","volume":"47","author":"Alder","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.biopha.2022.113710_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00506-18","article-title":"Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model","volume":"62","author":"Kidd","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.biopha.2022.113710_bib34","doi-asserted-by":"crossref","first-page":"e00745","DOI":"10.1128\/AAC.00745-18","article-title":"Variability of Daptomycin MIC Values for Enterococcus faecium When Measured by Reference Broth Microdilution and Gradient Diffusion Tests","volume":"62","author":"Campeau","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.biopha.2022.113710_bib35","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.00093-09","article-title":"Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2022.113710_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jac\/48.4.557","article-title":"Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media","volume":"48","author":"Fuchs","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2022.113710_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40262-014-0209-3","article-title":"Interethnic differences in pharmacokinetics of antibacterials","volume":"54","author":"Tsai","year":"2015","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.biopha.2022.113710_bib38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","article-title":"Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium","volume":"56","author":"Sakoulas","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.biopha.2022.113710_bib39","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/jac\/dku113","article-title":"Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic\/pharmacodynamic simulated endocardial vegetation model","volume":"69","author":"Hall Snyder","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2022.113710_bib40","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/AAC.02274-13","article-title":"Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium","volume":"58","author":"Sakoulas","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.biopha.2022.113710_bib41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijantimicag.2019.07.002","article-title":"Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia","volume":"54","author":"Avery","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.biopha.2022.113710_bib42","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41598-018-19986-8","article-title":"A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections","volume":"8","author":"Chuang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113710_bib43","series-title":"Handbook of Epidemiology","first-page":"639","article-title":"Misclassification","author":"Gustafson","year":"2014"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222201099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222201099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:08:04Z","timestamp":1781780884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222201099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":43,"alternative-id":["S075333222201099X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113710","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113710"}}